{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:15:17Z","timestamp":1791360917011,"version":"4.3.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metformin, a first-line treatment for type 2 diabetes, has gained attention as a promising neuroprotective agent due to its pleiotropic effects - including anti-inflammatory, anti-apoptotic, and autophagy-enhancing properties. Here we provide both preclinical and clinical evidence demonstrating the neuroprotective effects of metformin in the context of retinal ganglion cell (RGC) degeneration, a hallmark of glaucoma, a leading cause of irreversible blindness for which no direct RGC-neuroprotective therapies are currently available. In a mouse model of retinal ischemia\/reperfusion injury systemic administration of metformin significantly prevented RGC loss and preserved retinal structure. Enhanced phosphorylation of AMP-activated protein kinase (AMPK) was observed, along with increased autophagosome formation and upregulation of key mitophagy markers - including LC3II, optineurin, and Parkin - indicating improved mitochondrial quality control mechanisms. Proteomic analysis revealed that metformin modulated several proteins implicated in mitochondrial respiratory function, ubiquitination, and intracellular trafficking, suggesting broader effects on retinal cellular homeostasis. Complementing our preclinical observations, a retrospective clinical study in diabetic patients with glaucoma showed that individuals treated with metformin maintained stable visual field (VF) parameters over a six-month period, whereas those treated with insulin exhibited significant VF deterioration. These findings position metformin as a promising intraocular pressure (IOP)-independent neurotherapeutic for slowing or preventing glaucomatous neurodegeneration.<\/jats:p>","DOI":"10.1038\/s41420-025-02824-y","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:27:18Z","timestamp":1764005238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metformin protects retinal ganglion cells in a preclinical model of retinal ischemia\/reperfusion injury and stabilizes visual field in diabetic patients with glaucoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Andrea","family":"Satriano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Martucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-2642","authenticated-orcid":false,"given":"Annagrazia","family":"Adornetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Benfatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-828X","authenticated-orcid":false,"given":"Gianluca","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2550-3267","authenticated-orcid":false,"given":"Daniele","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-0697","authenticated-orcid":false,"given":"Maria Tiziana","family":"Corasaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-6523","authenticated-orcid":false,"given":"Rossella","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2824_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.preteyeres.2013.07.001","volume":"36","author":"DY Yu","year":"2013","unstructured":"Yu DY, Cringle SJ, Balaratnasingam C, Morgan WH, Yu PK, Su EN. Retinal ganglion cells: energetics, compartmentation, axonal transport, cytoskeletons and vulnerability. Prog Retin Eye Res. 2013;36:217\u201346.","journal-title":"Prog Retin Eye Res"},{"key":"2824_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2147\/OPTH.S3361","volume":"2","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2:879\u201389.","journal-title":"Clin Ophthalmol"},{"key":"2824_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081\u201390.","journal-title":"Ophthalmology"},{"key":"2824_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6138132","volume":"2020","author":"B Cvenkel","year":"2020","unstructured":"Cvenkel B, Kolko M. Current medical therapy and future trends in the management of glaucoma treatment. J Ophthalmol. 2020;2020:6138132.","journal-title":"J Ophthalmol"},{"key":"2824_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701\u201313.","journal-title":"Arch Ophthalmol"},{"key":"2824_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101303","volume":"103","author":"SG Asrani","year":"2024","unstructured":"Asrani SG, McGlumphy EJ, Al-Aswad LA, Chaya CJ, Lin S, Musch DC, et al. The relationship between intraocular pressure and glaucoma: An evolving concept. Prog Retin Eye Res. 2024;103:101303.","journal-title":"Prog Retin Eye Res"},{"key":"2824_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101225","volume":"94","author":"A Boccaccini","year":"2023","unstructured":"Boccaccini A, Cavaterra D, Carnevale C, Tanga L, Marini S, Bocedi A, et al. Novel frontiers in neuroprotective therapies in glaucoma: molecular and clinical aspects. Mol Asp Med. 2023;94:101225.","journal-title":"Mol Asp Med"},{"key":"2824_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1020993","volume":"9","author":"A Martucci","year":"2022","unstructured":"Martucci A, Mancino R, Cesareo M, Pinazo-Duran MD, Nucci C. Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma. Front Med. 2022;9:1020993.","journal-title":"Front Med"},{"key":"2824_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2016.04.030","volume":"787","author":"C Nucci","year":"2016","unstructured":"Nucci C, Russo R, Martucci A, Giannini C, Garaci F, Floris R, et al. New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system. Eur J Pharm. 2016;787:119\u201326.","journal-title":"Eur J Pharm"},{"key":"2824_CR10","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","volume":"60","author":"E Sanchez-Rangel","year":"2017","unstructured":"Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60:1586\u201393.","journal-title":"Diabetologia"},{"key":"2824_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","volume":"41","author":"L He","year":"2020","unstructured":"He L. Metformin and systemic metabolism. Trends Pharm Sci. 2020;41:868\u201381.","journal-title":"Trends Pharm Sci"},{"key":"2824_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig. 2001;108:1167\u201374.","journal-title":"J Clin Investig"},{"key":"2824_CR13","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1111\/jcmm.17519","volume":"26","author":"Y Bu","year":"2022","unstructured":"Bu Y, Peng M, Tang X, Xu X, Wu Y, Chen AF, et al. Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022;26:4886\u2013903.","journal-title":"J Cell Mol Med"},{"key":"2824_CR14","doi-asserted-by":"crossref","unstructured":"Isop LM, Neculau AE, Necula RD, Kakucs C, Moga MA, Dima L. Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders. Pharmaceuticals. 2023;16:1714.","DOI":"10.3390\/ph16121714"},{"key":"2824_CR15","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2147\/CMAR.S200059","volume":"11","author":"P Saraei","year":"2019","unstructured":"Saraei P, Asadi I, Kakar MA, Moradi-Kor N. The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019;11:3295\u2013313.","journal-title":"Cancer Manag Res"},{"key":"2824_CR16","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/JOE-21-0194","volume":"251","author":"R Krist\u00f3fi","year":"2021","unstructured":"Krist\u00f3fi R, Eriksson JW. Metformin as an anti-inflammatory agent: a short review. J Endocrinol. 2021;251:R11\u2013r22.","journal-title":"J Endocrinol"},{"key":"2824_CR17","doi-asserted-by":"crossref","unstructured":"Zhang T, Zhou L, Makarczyk MJ, Feng P, Zhang J. The anti-aging mechanism of metformin: from molecular insights to clinical applications. Molecules. 2025;30:816.","DOI":"10.3390\/molecules30040816"},{"key":"2824_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cmet.2020.04.015","volume":"32","author":"LP Bharath","year":"2020","unstructured":"Bharath LP, Agrawal M, McCambridge G, Nicholas DA, Hasturk H, Liu J, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 2020;32:44\u201355.e6.","journal-title":"Cell Metab"},{"key":"2824_CR19","doi-asserted-by":"publisher","first-page":"111286","DOI":"10.1016\/j.biopha.2021.111286","volume":"137","author":"G Lu","year":"2021","unstructured":"Lu G, Wu Z, Shang J, Xie Z, Chen C, Zhang C. The effects of metformin on autophagy. Biomed Pharmacother. 2021;137:111286.","journal-title":"Biomed Pharmacother"},{"key":"2824_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106114","volume":"177","author":"J Feng","year":"2022","unstructured":"Feng J, Wang X, Ye X, Ares I, Lopez-Torres B, Mart\u00ednez M, et al. Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications. Pharmacol Res. 2022;177:106114.","journal-title":"Pharmacol Res"},{"key":"2824_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/cdd.2011.88","volume":"19","author":"N Rodr\u00edguez-Muela","year":"2012","unstructured":"Rodr\u00edguez-Muela N, Germain F, Mari\u00f1o G, Fitze PS, Boya P. Autophagy promotes survival of retinal ganglion cells after optic nerve axotomy in mice. Cell Death Differ. 2012;19:162\u20139.","journal-title":"Cell Death Differ"},{"key":"2824_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fcell.2020.00121","volume":"8","author":"A Adornetto","year":"2020","unstructured":"Adornetto A, Parisi V, Morrone LA, Corasaniti MT, Bagetta G, Tonin P, et al. The role of autophagy in glaucomatous optic neuropathy. Front Cell Dev Biol. 2020;8:121.","journal-title":"Front Cell Dev Biol"},{"key":"2824_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41419-018-1044-5","volume":"9","author":"R Russo","year":"2018","unstructured":"Russo R, Varano GP, Adornetto A, Nazio F, Tettamanti G, Girardello R, et al. Rapamycin and fasting sustain autophagy response activated by ischemia\/reperfusion injury and promote retinal ganglion cell survival. Cell Death Dis. 2018;9:981.","journal-title":"Cell Death Dis"},{"key":"2824_CR24","doi-asserted-by":"crossref","unstructured":"Liton PB, Boesze-Battaglia K, Boulton ME, Boya P, Ferguson TA, Ganley IG, et al. Autophagy in the eye: from physiology to pathophysology. Autophagy Rep. 2023;2:2178996.","DOI":"10.1080\/27694127.2023.2178996"},{"key":"2824_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.29","volume":"2","author":"R Russo","year":"2011","unstructured":"Russo R, Berliocchi L, Adornetto A, Varano GP, Cavaliere F, Nucci C, et al. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo. Cell Death Dis. 2011;2:e144.","journal-title":"Cell Death Dis"},{"key":"2824_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaophthalmol.2015.1440","volume":"133","author":"HC Lin","year":"2015","unstructured":"Lin HC, Stein JD, Nan B, Childers D, Newman-Casey PA, Thompson DA, et al. Association of geroprotective effects of metformin and risk of open-angle glaucoma in persons with Diabetes Mellitus. JAMA Ophthalmol. 2015;133:915\u201323.","journal-title":"JAMA Ophthalmol"},{"key":"2824_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5644\/ama2006-124.196","volume":"46","author":"S Male\u0161ki\u0107","year":"2017","unstructured":"Male\u0161ki\u0107 S, Kusturica J, Gu\u0161i\u0107 E, Rakanovi\u0107-Todi\u0107 M, \u0160e\u010di\u0107 D, Burnazovi\u0107-Risti\u0107 L, et al. Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study. Acta Med Acad. 2017;46:116\u201323.","journal-title":"Acta Med Acad"},{"key":"2824_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","volume":"140","author":"JE Vergroesen","year":"2022","unstructured":"Vergroesen JE, Thee EF, Ahmadizar F, van Duijn CM, Stricker BH, Kavousi M, et al. Association of diabetes medication with open-angle glaucoma, age-related macular degeneration, and cataract in the rotterdam study. JAMA Ophthalmol. 2022;140:674\u201381.","journal-title":"JAMA Ophthalmol"},{"key":"2824_CR29","doi-asserted-by":"crossref","unstructured":"Bosnyak I, Farkas N, Molitor D, Meresz B, Patko E, Atlasz T, et al. Optimization of an ischemic retinopathy mouse model and the consequences of hypoxia in a time-dependent manner. Int J Mol Sci. 2024;25:8008.","DOI":"10.3390\/ijms25158008"},{"key":"2824_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retinal Eye Res. 2004;23:91\u2013147.","journal-title":"Prog Retinal Eye Res"},{"key":"2824_CR31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/ejn.12556","volume":"39","author":"VR Venna","year":"2014","unstructured":"Venna VR, Li J, Hammond MD, Mancini NS, McCullough LD. Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke. Eur J Neurosci. 2014;39:2129\u201338.","journal-title":"Eur J Neurosci"},{"key":"2824_CR32","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s11064-016-1988-8","volume":"41","author":"T Deng","year":"2016","unstructured":"Deng T, Zheng YR, Hou WW, Yuan Y, Shen Z, Wu XL, et al. Pre-stroke metformin treatment is neuroprotective involving AMPK reduction. Neurochem Res. 2016;41:2719\u201327.","journal-title":"Neurochem Res"},{"key":"2824_CR33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60:1577\u201385.","journal-title":"Diabetologia"},{"key":"2824_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66:789\u2013800.","journal-title":"Mol Cell"},{"key":"2824_CR35","doi-asserted-by":"crossref","unstructured":"Chung KW, Chung HY. The effects of calorie restriction on autophagy: role on aging intervention. Nutrients. 2019;11:2923.","DOI":"10.3390\/nu11122923"},{"key":"2824_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101240","volume":"66","author":"J Martel","year":"2021","unstructured":"Martel J, Chang SH, Wu CY, Peng HH, Hwang TL, Ko YF, et al. Recent advances in the field of caloric restriction mimetics and anti-aging molecules. Ageing Res Rev. 2021;66:101240.","journal-title":"Ageing Res Rev"},{"key":"2824_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021;17:1\u2013382.","journal-title":"Autophagy"},{"key":"2824_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.793328","volume":"10","author":"AV Kumar","year":"2022","unstructured":"Kumar AV, Mills J, Lapierre LR. Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging. Front cell Dev Biol. 2022;10:793328.","journal-title":"Front cell Dev Biol"},{"key":"2824_CR39","doi-asserted-by":"crossref","unstructured":"Zaffagnini G, Savova A, Danieli A, Romanov J, Tremel S, Ebner M, et al. p62 filaments capture and present ubiquitinated cargos for autophagy. EMBO J. 2018;37:e98308.","DOI":"10.15252\/embj.201798308"},{"key":"2824_CR40","doi-asserted-by":"publisher","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","volume":"111","author":"YC Wong","year":"2014","unstructured":"Wong YC, Holzbaur EL. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci USA. 2014;111:E4439\u201348.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2824_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129972","volume":"1865","author":"K Yamano","year":"2021","unstructured":"Yamano K, Kojima W. Molecular functions of autophagy adaptors upon ubiquitin-driven mitophagy. Biochim et Biophys Acta Gen Subj. 2021;1865:129972.","journal-title":"Biochim et Biophys Acta Gen Subj"},{"key":"2824_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2015.08.016","volume":"60","author":"JM Heo","year":"2015","unstructured":"Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN\/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60:7\u201320.","journal-title":"Mol Cell"},{"key":"2824_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309\u201314.","journal-title":"Nature"},{"key":"2824_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","volume":"33","author":"A Eiyama","year":"2015","unstructured":"Eiyama A, Okamoto K. PINK1\/Parkin-mediated mitophagy in mammalian cells. Curr Opin cell Biol. 2015;33:95\u2013101.","journal-title":"Curr Opin cell Biol"},{"key":"2824_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1083\/jcb.201110114","volume":"196","author":"K Moreau","year":"2012","unstructured":"Moreau K, Ravikumar B, Puri C, Rubinsztein DC. Arf6 promotes autophagosome formation via effects on phosphatidylinositol 4,5-bisphosphate and phospholipase D. J cell Biol. 2012;196:483\u201396.","journal-title":"J cell Biol"},{"key":"2824_CR46","doi-asserted-by":"crossref","unstructured":"Cason SE, Holzbaur ELF. Axonal transport of autophagosomes is regulated by dynein activators JIP3\/JIP4 and ARF\/RAB GTPases. J Cell Biol. 2023;222:e202301084.","DOI":"10.1083\/jcb.202301084"},{"key":"2824_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156040","volume":"162","author":"S Saha","year":"2025","unstructured":"Saha S, Mandal A, Ranjan A, Ghosh DK. Membrane tension sensing formin-binding protein 1 is a neuronal nutrient stress-responsive Golgiphagy receptor. Metab Clin Exp. 2025;162:156040.","journal-title":"Metab Clin Exp"},{"key":"2824_CR48","doi-asserted-by":"crossref","unstructured":"McGrath MJ, Eramo MJ, Gurung R, Sriratana A, Gehrig SM, Lynch GS, et al. Defective lysosome reformation during autophagy causes skeletal muscle disease. J Clin Investig. 2021;131:e135124.","DOI":"10.1172\/JCI135124"},{"key":"2824_CR49","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","volume":"34","author":"M Markowicz-Piasecka","year":"2017","unstructured":"Markowicz-Piasecka M, Sikora J, Szyd\u0142owska A, Skupie\u0144 A, Mikiciuk-Olasik E, Huttunen KM. Metformin - a future therapy for neurodegenerative diseases : theme: drug discovery, development and delivery in Alzheimer\u2019s disease Guest Editor: Davide Brambilla. Pharm Res. 2017;34:2614\u201327.","journal-title":"Pharm Res"},{"key":"2824_CR50","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4103\/1673-5374.385286","volume":"19","author":"A Loan","year":"2024","unstructured":"Loan A, Syal C, Lui M, He L, Wang J. Promising use of metformin in treating neurological disorders: biomarker-guided therapies. Neural Regen Res. 2024;19:1045\u201355.","journal-title":"Neural Regen Res"},{"key":"2824_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"75","author":"IH Pang","year":"2020","unstructured":"Pang IH, Clark AF. Inducible rodent models of glaucoma. Prog Retin Eye Res. 2020;75:100799.","journal-title":"Prog Retin Eye Res"},{"key":"2824_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11011-013-9475-2","volume":"29","author":"G Ashabi","year":"2014","unstructured":"Ashabi G, Khodagholi F, Khalaj L, Goudarzvand M, Nasiri M. Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK\/PGC-1\u03b1 pathway. Metab Brain Dis. 2014;29:47\u201358.","journal-title":"Metab Brain Dis"},{"key":"2824_CR53","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1161\/STROKEAHA.110.589697","volume":"41","author":"J Li","year":"2010","unstructured":"Li J, Benashski SE, Venna VR, McCullough LD. Effects of metformin in experimental stroke. Stroke. 2010;41:2645\u201352.","journal-title":"Stroke"},{"key":"2824_CR54","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/hmg\/ddv513","volume":"25","author":"RP V\u00e1zquez-Manrique","year":"2016","unstructured":"V\u00e1zquez-Manrique RP, Farina F, Cambon K, Dolores Sequedo M, Parker AJ, Mill\u00e1n JM, et al. AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington\u2019s disease. Hum Mol Genet. 2016;25:1043\u201358.","journal-title":"Hum Mol Genet"},{"key":"2824_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104557","volume":"377","author":"X Wang","year":"2022","unstructured":"Wang X, Liu Y, Han D, Zhong J, Yang C, Chen X. Dose-dependent immunomodulatory effects of metformin on human neonatal monocyte-derived macrophages. Cell Immunol. 2022;377:104557.","journal-title":"Cell Immunol"},{"key":"2824_CR56","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang Y, An H, Liu T, Qin C, Sesaki H, Guo S, et al. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep. 2019;29:1511\u201323.e5.","journal-title":"Cell Rep"},{"key":"2824_CR57","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s10238-023-01051-y","volume":"23","author":"H Zhu","year":"2023","unstructured":"Zhu H, Jia Z, Li YR, Danelisen I. Molecular mechanisms of action of metformin: latest advances and therapeutic implications. Clin Exp Med. 2023;23:2941\u201351.","journal-title":"Clin Exp Med"},{"key":"2824_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","volume":"25","author":"JJ Howell","year":"2017","unstructured":"Howell JJ, Hellberg K, Turner M, Talbott G, Kolar MJ, Ross DS, et al. Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex. Cell Metab. 2017;25:463\u201371.","journal-title":"Cell Metab"},{"key":"2824_CR59","doi-asserted-by":"publisher","first-page":"e114573","DOI":"10.1371\/journal.pone.0114573","volume":"9","author":"M Ming","year":"2014","unstructured":"Ming M, Sinnett-Smith J, Wang J, Soares HP, Young SH, Eibl G, et al. Dose-dependent AMPK-dependent and independent mechanisms of berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in pancreatic cancer cells. PloS ONE. 2014;9:e114573.","journal-title":"PloS ONE"},{"key":"2824_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phrs.2016.03.010","volume":"107","author":"Y Song","year":"2016","unstructured":"Song Y, Wu Y, Su X, Zhu Y, Liu L, Pan Y, et al. Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms. Pharmacol Res. 2016;107:117\u201324.","journal-title":"Pharmacol Res"},{"key":"2824_CR61","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331:456\u201361.","journal-title":"Science"},{"key":"2824_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3233\/JPD-171296","volume":"8","author":"DW Curry","year":"2018","unstructured":"Curry DW, Stutz B, Andrews ZB, Elsworth JD. Targeting AMPK signaling as a neuroprotective strategy in Parkinson\u2019s disease. J Parkinson\u2019s Dis. 2018;8:161\u201381.","journal-title":"J Parkinson\u2019s Dis"},{"key":"2824_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","volume":"21","author":"S Demar\u00e9","year":"2021","unstructured":"Demar\u00e9 S, Kothari A, Calcutt NA, Fernyhough P. Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system. Expert Rev Neurother. 2021;21:45\u201363.","journal-title":"Expert Rev Neurother"},{"key":"2824_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.838173","volume":"14","author":"MR Du","year":"2022","unstructured":"Du MR, Gao QY, Liu CL, Bai LY, Li T, Wei FL. Exploring the pharmacological potential of metformin for neurodegenerative diseases. Front Aging Neurosci. 2022;14:838173.","journal-title":"Front Aging Neurosci"},{"key":"2824_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1096\/fj.10-167361","volume":"25","author":"V Vingtdeux","year":"2011","unstructured":"Vingtdeux V, Chandakkar P, Zhao H, d\u2019Abramo C, Davies P, Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-\u03b2 peptide degradation. FASEB J. 2011;25:219\u201331.","journal-title":"FASEB J"},{"key":"2824_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00466-z","volume":"16","author":"N Belforte","year":"2021","unstructured":"Belforte N, Agostinone J, Alarcon-Martinez L, Villafranca-Baughman D, Dotigny F, Cueva Vargas JL, et al. AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma. Mol Neurodegener. 2021;16:43.","journal-title":"Mol Neurodegener"},{"key":"2824_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1346-7","volume":"15","author":"M Harun-Or-Rashid","year":"2018","unstructured":"Harun-Or-Rashid M, Inman DM. Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma. J Neuroinflamm. 2018;15:313.","journal-title":"J Neuroinflamm"},{"key":"2824_CR68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/978-3-030-27378-1_78","volume":"1185","author":"EE Brown","year":"2019","unstructured":"Brown EE, Lewin AS, Ash JD. AMPK may play an important role in the retinal metabolic ecosystem. Adv Exp Med Biol. 2019;1185:477\u201381.","journal-title":"Adv Exp Med Biol"},{"key":"2824_CR69","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1016\/j.apsb.2023.06.008","volume":"13","author":"D Sun","year":"2023","unstructured":"Sun D, Guo Y, Tang P, Li H, Chen L. Arf6 as a therapeutic target: structure, mechanism, and inhibitors. Acta Pharma Sin B. 2023;13:4089\u2013104.","journal-title":"Acta Pharma Sin B"},{"key":"2824_CR70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-017-0146-9","volume":"9","author":"Y Dai","year":"2018","unstructured":"Dai Y, Hu X, Sun X. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma. Cell Death Dis. 2018;9:88.","journal-title":"Cell Death Dis"},{"key":"2824_CR71","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddq419","volume":"19","author":"ME Gegg","year":"2010","unstructured":"Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1\/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet. 2010;19:4861\u201370.","journal-title":"Hum Mol Genet"},{"key":"2824_CR72","doi-asserted-by":"publisher","first-page":"102852","DOI":"10.18632\/oncotarget.9913","volume":"8","author":"B Pascucci","year":"2017","unstructured":"Pascucci B, D\u2019Errico M, Romagnoli A, De Nuccio C, Savino M, Pietraforte D, et al. Overexpression of parkin rescues the defective mitochondrial phenotype and the increased apoptosis of Cockayne Syndrome A cells. Oncotarget. 2017;8:102852\u201367.","journal-title":"Oncotarget"},{"key":"2824_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.108979","volume":"217","author":"HL Liu","year":"2022","unstructured":"Liu HL, Hu FY, Xu P, Wu JH. Regulation of mitophagy by metformin improves the structure and function of retinal ganglion cells following excitotoxicity-induced retinal injury. Exp Eye Res. 2022;217:108979.","journal-title":"Exp Eye Res"},{"key":"2824_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102786","volume":"64","author":"P Sekar","year":"2023","unstructured":"Sekar P, Hsiao G, Hsu SH, Huang DY, Lin WW, Chan CM. Metformin inhibits methylglyoxal-induced retinal pigment epithelial cell death and retinopathy via AMPK-dependent mechanisms: Reversing mitochondrial dysfunction and upregulating glyoxalase 1. Redox Biol. 2023;64:102786.","journal-title":"Redox Biol"},{"key":"2824_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2023.05.019","volume":"205","author":"K Zhang","year":"2023","unstructured":"Zhang K, Wang T, Sun GF, Xiao JX, Jiang LP, Tou FF, et al. Metformin protects against retinal ischemia\/reperfusion injury through AMPK-mediated mitochondrial fusion. Free Radic Biol Med. 2023;205:47\u201361.","journal-title":"Free Radic Biol Med"},{"key":"2824_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.705405","volume":"12","author":"F Conti","year":"2021","unstructured":"Conti F, Romano GL, Eandi CM, Toro MD, Rejdak R, Di Benedetto G, et al. Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage. Front Pharmacol. 2021;12:705405.","journal-title":"Front Pharmacol"},{"key":"2824_CR77","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/IJG.0000000000002260","volume":"32","author":"B Melchior","year":"2023","unstructured":"Melchior B, De Moraes CG, Paula JS, Cioffi GA, Gordon MO, Kass MA, et al. What is the optimal frequency of visual field testing to detect rapid progression among hypertensive eyes?. J Glaucoma. 2023;32:721\u20134.","journal-title":"J Glaucoma"},{"key":"2824_CR78","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ophtha.2023.12.031","volume":"131","author":"FA Medeiros","year":"2024","unstructured":"Medeiros FA, Malek DA, Tseng H, Swaminathan SS, Boland MV, Friedman DS, et al. Short-term detection of fast progressors in glaucoma: the fast progression assessment through clustered evaluation (Fast-PACE) Study. Ophthalmology. 2024;131:645\u201357.","journal-title":"Ophthalmology"},{"key":"2824_CR79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/bjo-2023-325035","volume":"109","author":"T Nishida","year":"2024","unstructured":"Nishida T, Moghimi S, Gunasegaran G, Walker E, Wu JH, Rahmatnejad K, et al. Association between metformin use with circumpapillary retinal nerve fibre layer thickness and capillary vessel density in glaucoma. Br J Ophthalmol. 2024;109:45\u201351.","journal-title":"Br J Ophthalmol"},{"key":"2824_CR80","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tem.2012.03.004","volume":"23","author":"D Ma","year":"2012","unstructured":"Ma D, Li S, Molusky MM, Lin JD. Circadian autophagy rhythm: a link between clock and metabolism?. Trends Endocrinol Metab. 2012;23:319\u201325.","journal-title":"Trends Endocrinol Metab"},{"key":"2824_CR81","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","volume":"18","author":"TS Batth","year":"2019","unstructured":"Batth TS, Tollenaere MX, R\u00fcther P, Gonzalez-Franquesa A, Prabhakar BS, Bekker-Jensen S, et al. Protein aggregation capture on microparticles enables multipurpose proteomics sample preparation. Mol Cell Proteom. 2019;18:1027\u201335.","journal-title":"Mol Cell Proteom"},{"key":"2824_CR82","doi-asserted-by":"crossref","unstructured":"Prestagiacomo LE, Gabriele C, Morelli P, Rota MA, Alba S, Cuda G, et al. Proteomic Profile of EPS-Urine through FASP digestion and data-independent analysis. J Visual Exp. 2021;171:e62512.","DOI":"10.3791\/62512-v"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02824-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:10Z","timestamp":1764180790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02824-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2824"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02824-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"546"}}